Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

NCT07280832 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable Locally Advanced or Metastatic Melanoma

Interventions

DRUG: JMT108

Sponsor

Shanghai JMT-Bio Inc.